InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Huang Dennis Karl, Vice-Président Exécutif et Responsable des Opérations Technologiques. Insider active across 1 company, notably Ultragenyx Pharmaceutical Inc.. Cumulatively, 8 reports have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €251k. Activity tracked since 6 May 2021. The latest transaction was disclosed on 16 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Huang Dennis Karl
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
23,116 股0Common StockSEC:0001193125-26-164297:0
11,137 股0Common StockSEC:0001193125-26-089102:0
14,494 股0Common StockSEC:0000950170-25-032767:0
17,800 股0Common StockSEC:0000950170-24-026652:0
2,663 股0Common StockSEC:0001209191-23-016043:0
3,234 股@ US$66.620.0078% mcap61.8% 占其流量Common StockSEC:0001209191-22-015815:0
358 股@ US$81.1410.0% 占其流量Common StockSEC:0001209191-21-060759:0
363 股@ US$113.6813.6% 占其流量Common StockSEC:0001209191-21-031390:0
8 条申报中的 8 条
About Huang Dennis Karl
Dennis Karl Huang serves as Executive Vice President and Chief Tech Ops Officer of Ultragenyx Pharmaceutical Inc. He oversees the company's technological operations and plays a key role in developing innovative solutions. His technical expertise is an asset for Ultragenyx in the pharmaceutical sector.
